KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 128 filers reported holding KYMERA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,376,823 | -55.8% | 99,052 | -27.0% | 0.00% | -100.0% |
| Q2 2023 | $3,117,995 | +62.5% | 135,624 | +109.4% | 0.00% | 0.0% |
| Q1 2023 | $1,919,254 | +9.9% | 64,774 | -7.5% | 0.00% | 0.0% |
| Q4 2022 | $1,747,125 | +32.2% | 69,997 | +15.3% | 0.00% | 0.0% |
| Q3 2022 | $1,322,000 | -40.0% | 60,724 | +16.6% | 0.00% | – |
| Q1 2022 | $2,203,000 | -72.6% | 52,070 | -58.9% | 0.00% | -100.0% |
| Q4 2021 | $8,051,000 | +133.3% | 126,804 | +115.8% | 0.00% | +200.0% |
| Q3 2021 | $3,451,000 | +119.8% | 58,747 | +45.4% | 0.00% | 0.0% |
| Q1 2021 | $1,570,000 | +630.2% | 40,394 | +1066.4% | 0.00% | – |
| Q4 2020 | $215,000 | – | 3,463 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 457,059 | $9,950,000 | 17.03% |
| Atlas Venture Life Science Advisors, LLC | 6,875,698 | $149,684,000 | 16.52% |
| BVF INC/IL | 4,692,604 | $102,158,000 | 4.22% |
| Aquilo Capital Management, LLC | 330,246 | $7,189,000 | 2.59% |
| Redmile Group, LLC | 2,876,637 | $62,624,000 | 2.43% |
| Artal Group S.A. | 1,500,000 | $32,655,000 | 1.39% |
| Deer Management Co. LLC | 615,895 | $13,408,000 | 0.94% |
| Avoro Capital Advisors LLC | 2,169,230 | $47,224,000 | 0.87% |
| AtonRa Partners | 34,462 | $750,000 | 0.74% |
| Rock Springs Capital Management LP | 1,046,743 | $22,788,000 | 0.59% |